SCHEMBL4144739

SCHEMBL4144739

CN(C(=O)NCc1ccccc1)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
ATM Q13315 1/20 0.46
PTPRZ1 P23471 3/20 0.44
ALDH1A1 P00352 5/20 0.44
PTPN1 P18031 2/20 0.43
KMT2A Q03164 2/20 0.43
EPHX2 P34913 1/20 0.42
NR1H4 Q96RI1 1/20 0.42
OPRM1 P35372 1/20 0.39
OPRL1 P41146 1/20 0.39
RORC P51449 1/20 0.39
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
TSHR P16473 2/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13774610 0.89 PTPRZ1 (0.39) MAPTATMPTPRZ1ALDH1A1PTPN1
SCHEMBL4154163 0.88 KMT2A (0.44) MAPTALDH1A1KMT2AMEN1LMNA
SCHEMBL4155698 0.87 PTPRZ1 (0.44) PTPRZ1ALDH1A1PTPN1KMT2AEPHX2
SCHEMBL4145579 0.87 ROCK2 (0.48) ALDH1A1KMT2AEPHX2MEN1HPGD
SCHEMBL4142022 0.84 PTPRZ1 (0.37) MAPTPTPRZ1ALDH1A1PTPN1EPHX2
SCHEMBL5313318 0.84 MAPT (0.42) MAPTATMPTPRZ1ALDH1A1PTPN1
SCHEMBL4150041 0.84 ALDH1A1 (0.43) MAPTALDH1A1KMT2AMEN1NPC1
SCHEMBL4150851 0.83 PTPRZ1 (0.36) MAPTPTPRZ1ALDH1A1PTPN1EPHX2
SCHEMBL4157346 0.83 HPGD (0.47) ALDH1A1KMT2AMEN1HPGDL3MBTL1
SCHEMBL4145085 0.83 HPGD (0.43) MAPTALDH1A1KMT2AEPHX2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 MAPT 4585/4885ATM 2385/4885PTPRZ1 1175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.